NCT00666978 Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking Status COMPLETED Phase PHASE4
NCT00665912 Platelet-Rich and Concentrated Platelet-Poor Plasma to Reduce Air Leak Post-Lobectomy: A Randomized Controlled Trial Status COMPLETED Phase NA
NCT00664105 Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC) Status TERMINATED Phase PHASE2
NCT00661193 S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00660816 Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00660504 Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-cisplatin for Extensive Disease Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00659568 Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma Status COMPLETED Phase PHASE1
NCT00653367 Evaluation of Chronic Pain After Nerve Section During Thoracotomy Status WITHDRAWN Phase NA
NCT00653250 Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer Status COMPLETED Phase NA
NCT00643370 Quantifying Lung Tumor Movement Under Deep Inspiration Breath Holds Status COMPLETED Phase N/A
NCT00632853 Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Status UNKNOWN Phase PHASE3
NCT00625690 CT Scans in Screening for Lung Cancer in Current and Former Smokers Status COMPLETED Phase N/A
NCT00625456 Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT00622674 Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00621361 Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients Status COMPLETED Phase PHASE1
NCT00620347 Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00620295 Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00620269 Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III Status UNKNOWN Phase PHASE2